Cellular Therapy and Hematologic Malignancies

Grand Rounds


Speaker:             Joanne Kurtzberg, M.D.

Professor of Pediatrics

Professor of Pathology

Chief Scientific Officer, Robertson Clinical and

   Translational Cell Therapy Program

Chief, Div. of Pediatric Blood & Marrow Transplantation

Co-Director, Stem Cell Laboratory

Director, Carolinas Cord Blood Bank


Topic:                  The potential for cord blood derived cellular therapies to treat genetic and acquired brain injuries.


Date:                          Tuesday, March 31, 2015


Time:                         12:00 p.m. – 1:00 p.m.


Location:                  CR 9015 North Pavilion


Faculty (Speaker) Disclosure:  Dr. Joanne Kurtzberg discloses the following personal/financial relationships which are relevant to this activity:  Principal Investigator for Aldagen; Advisory Board Member for CORD:USE; Principal Investigator for Gamida Cell; Consultant for NMDP.

Activity Medical Director/Planning Committee Disclosure(s):  Dr. Mitchell Horwitz discloses the following personal/financial relationships which are relevant to this activity:  Advisory Board Member for Genzyme; Principal Investigator for both Otsuka and Pfizer.


Accreditation: The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credit Designation: The Duke University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)ä.  Physicians should only claim credit commensurate with the extent of their participation in the activity.


Unapproved Use Disclosure: Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty at this symposium may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling.  This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


You must text the six letter code provided by the speaker to (919)213-8033 to receive credit for attending this conference.


Please feel free to bring your lunch to this event, as lunch is not provided.

Session date: 
Tuesday, March 31, 2015 - 12:00pm to 1:00pm
North Pavilion
2400 Pratt Street
Durham, NC 27705
United States

Please login or register to take this course.